Knowledge of laboratory diagnosis | Frequency (n = 131) | Percentage (100%) | |||||
According to CDC, the following specimens can be used in the laboratory detection of SARS-CoV-2 Blood Oropharyngeal/Throat Swab Feaces Vaginal/Urethral Swab Nasopharyngeal/Nasal Swabs CSF |
62 108 10 8 92 11 |
47.3 82.4 7.6 6.1 70.2 8.4 | |||||
CDC criteria for specimen rejection for COVID-19 testing Specimens not kept at 2-4 degree Celsius Incomplete specimen labeling or documentation Undiluted specimen Inappropriate specimen type |
63 105 19 99 |
48.1 80.2 14.5 75.6 | |||||
Single Double Triple Galvanized Aerated | 21 32 36 30 12 | 16.0 24.4 27.5 22.9 9.2 | |||||
One of the hallmarks of COVID-19 Lymphocytosis Lymphopenia Increased LDH Increased Albumin Prolong PT |
81 49 27 26 18 |
61.8 37.4 20.6 19.8 13.7 | |||||
Arrange the following Coronavirus detection steps in the right order: Fluorescent signal detection, 2. Reverse transcription of RNA to cDNA, 3. RNA isolation 4. cDNA amplification with real-time PCR, 5. RNA purification 1 5 3 4 2 2 3 4 5 1 5 4 2 1 3 3 5 2 4 1 4 1 5 4 3 2 | 24 14 24 59 0 | 18.3 10.7 18.3 45.0 7.6 | |||||
| Strongly agree n (%) | Agree n (%) | Slightly agree n (%) | Slightly disagree n (%) | Disagree n (%) | Strongly disagree n (%)
| |
The collected specimen must be put into a viral transport medium | 78 (59.5) | 48 (36.6) | 2 (1.5) | 1 (0.8) | 2 (1.5) | 0 (0.0) | |
Diffuse alveolar damage characterized by presence of cellular fibromyxoid exudates, desquamation of pneumocytes and hyaline membrane formation is diagnostic pulmonary histology in COVID-19 | 38 (29.0) | 61 (46.6) | 20 (15.2) | 8 (6.1) | 4 (3.1) | 0 (0.0) | |
Total | 131 | 100 |